Treatment Approaches Based on Neuroscientific Data in Patients With Obsessive-Compulsive Disorder
International Clinical Neuroscience Journal,
Vol. 8 No. 3 (2021),
30 June 2021
,
Page 107-117
Abstract
Background: Obsessive-compulsive disorder (OCD) is a severe psychological disorder that can be very disabling. Recent increasing neuroscientific data about OCD has provided important evidence that has started to change our knowledge about treatment. This paper offers an applied perspective of neuroscience on diagnosis and treatment preparation for people with OCD disease. The main aim is to enhance clinician-researcher communication to promote the conversion of developments in neuroscience research into better treatment for patients with OCD.
Methods: A PubMed search was performed using the keywords “obsessive-compulsive disorder”, “neuroimaging methods”, “neuroscience”, and “neurological treatment”. The search provided sufficient articles published in peer-reviewed journals from 1995 to 2021. The data were obtained from these various sources and were included in this review.
Results: The advancement of neurotherapeutic techniques targeting the cortico-striatal-thalamo-cortical (CSTC) circuit is the subject of a circuit dysregulation system. Also, according to neuroimaging studies, reductions in D2 receptors (about -18%), GABAA receptors (-15%), and cingulate 5-HT1A receptors (-18%) in patients with OCD were reported compared with healthy controls.
Conclusion: The result suggests that DA, 5-HT, and GABA have considerable roles in anxiety- and compulsion-related disorders such as OCD. For patients with OCD, these core neuroscience themes collectively guide formulation and clinical preparation.
- Obsessive-compulsive disorder
- OCD
- Neuroscience
- Neuro-treatment
- CSTC loops
- Neuroimaging
How to Cite
References
Park NY. OCD and errors in financial decisions. Econ Bull. 2018;38(4):1970-7.
Angelakis I, Gooding P, Tarrier N, Panagioti M. Suicidality in obsessive compulsive disorder (OCD): a systematic review and meta-analysis. Clin Psychol Rev. 2015;39:1-15. doi: 10.1016/j.cpr.2015.03.002.
Stein DJ, Costa DLC, Lochner C, Miguel EC, Reddy YCJ, Shavitt RG, et al. Obsessive-compulsive disorder. Nat Rev Dis Primers. 2019;5(1):52. doi: 10.1038/s41572-019-0102- 3.
Shephard E, Stern ER, van den Heuvel OA, Costa DLC, Batistuzzo MC, Godoy PBG, et al. Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder. Mol Psychiatry. 2021. doi: 10.1038/ s41380-020-01007-8.
Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53-63. doi: 10.1038/mp.2008.94.
Anholt GE, Aderka IM, van Balkom AJ, Smit JH, Schruers K, van der Wee NJ, et al. Age of onset in obsessive-compulsive disorder: admixture analysis with a large sample. Psychol Med. 2014;44(1):185-94. doi: 10.1017/s0033291713000470.
Pinto A, Mancebo MC, Eisen JL, Pagano ME, Rasmussen SA. The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. J Clin Psychiatry. 2006;67(5):703-11. doi: 10.4088/jcp. v67n0503.
Subramaniam M, Soh P, Vaingankar JA, Picco L, Chong SA. Quality of life in obsessive-compulsive disorder: impact of the disorder and of treatment. CNS Drugs. 2013;27(5):367- 83. doi: 10.1007/s40263-013-0056-z.
Ramos-Cerqueira AT, Torres AR, Torresan RC, Negreiros AP, Vitorino CN. Emotional burden in caregivers of patients with obsessive-compulsive disorder. Depress Anxiety. 2008;25(12):1020-7. doi: 10.1002/da.20431.
Foa EB, Yadin E, Lichner TK. Exposure and Response (Ritual) Prevention for Obsessive Compulsive Disorder: Therapist Guide. Oxford University Press; 2012.
Meyer V. Modification of expectations in cases with obsessional rituals. Behav Res Ther. 1966;4(4):273-80. doi: 10.1016/0005-7967(66)90023-4.
Foa EB, Goldstein A. Continuous exposure and complete response prevention in the treatment of obsessive-compulsive neurosis. Behav Ther. 1978;9(5):821-9. doi: 10.1016/s0005-7894(78)80013-6.
Pittenger C, Kelmendi B, Bloch M, Krystal JH, Coric V. Clinical treatment of obsessive compulsive disorder. Psychiatry (Edgmont). 2005;2(11):34-43.
Stein DJ, Rapoport JL. Cross-cultural studies and obsessive-compulsive disorder. CNS Spectr. 1996;1(1):42-6. doi: 10.1017/S1092852900000675.
Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry. 1992;49(9):690-4. doi: 10.1001/ archpsyc.1992.01820090018003.
Miguel EC, do Rosário-Campos MC, Shavitt RG, Hounie AG, Mercadante MT. The tic-related obsessive-compulsive disorder phenotype and treatment implications. Adv Neurol. 2001;85:43-55.
Ames D, Cummings JL, Wirshing WC, Quinn B, Mahler M. Repetitive and compulsive behavior in frontal lobe degenerations. J Neuropsychiatry Clin Neurosci. 1994;6(2):100-13. doi: 10.1176/jnp.6.2.100.
Gholampour S, Bahmani M. Hydrodynamic comparison of shunt and endoscopic third ventriculostomy in adult hydrocephalus using in vitro models and fluid-structure interaction simulation. Comput Methods Programs Biomed. 2021;204:106049. doi: 10.1016/j. cmpb.2021.106049.
Amir N, Freshman M, Ramsey B, Neary E, Brigidi B. Thought-action fusion in individuals with OCD symptoms. Behav Res Ther. 2001;39(7):765-76. doi: 10.1016/s0005- 7967(00)00056-5.
Nedeljkovic M, Moulding R, Kyrios M, Doron G. The relationship of cognitive confidence to OCD symptoms. J Anxiety Disord. 2009;23(4):463-8. doi: 10.1016/j. janxdis.2008.10.001.
Spitzer RL, Wakefield JC. DSM-IV diagnostic criterion for clinical significance: does it help solve the false positives problem? Am J Psychiatry. 1999;156(12):1856-64. doi: 10.1176/ajp.156.12.1856.
Hashemi Goradel N, Baker AT, Arashkia A, Ebrahimi N, Ghorghanlu S, Negahdari B. Oncolytic virotherapy: challenges and solutions. Curr Probl Cancer. 2021;45(1):100639. doi: 10.1016/j. currproblcancer.2020.100639.
Ebrahimi N, Amirmahani F, Sadeghi B, Ghanaatian M. Trichoderma longibrachiatum derived metabolite as a potential source of anti‐breast‐cancer agent. Biologia. 2021;76(5):1595-601. doi: 10.1007/s11756-021-00705-0.
Stasik SM, Naragon-Gainey K, Chmielewski M, Watson D. Core OCD symptoms: exploration of specificity and relations with psychopathology. J Anxiety Disord. 2012;26(8):859-70. doi: 10.1016/j.janxdis.2012.07.007.
Stein DJ, Allen A, Bobes J, Eisen JL, Figuera ML, Iikura Y, et al. Quality of life in obsessive-compulsive disorder. CNS Spectr. 2000;5(S4):37-9. doi: 10.1017/s1092852900025025.
Ghanaat M, Hashemi Goradel N, Arashkia A, Ebrahimi N, Ghorghanlu S, Veisi Malekshahi Z, et al. Virus against virus: strategies for using adenovirus vectors in the treatment of HPV-induced cervical cancer. Acta Pharmacol Sin. 2021. doi: 10.1038/s41401-021-00616-5.
Goodman WK. Obsessive-compulsive disorder: diagnosis and treatment. J Clin Psychiatry. 1999;60 Suppl 18:27-32.
Nazeer A, Latif F, Mondal A, Azeem MW, Greydanus DE. Obsessive-compulsive disorder in children and adolescents: epidemiology, diagnosis and management. Transl Pediatr. 2020;9(Suppl 1):S76-S93. doi: 10.21037/tp.2019.10.02.
Rajendram R, Kronenberg S, Burton CL, Arnold PD. Glutamate genetics in obsessive-compulsive disorder: a review. J Can Acad Child Adolesc Psychiatry. 2017;26(3):205-13.
Bozorgmehr A, Ghadirivasfi M, Shahsavand Ananloo E. Obsessive-compulsive disorder, which genes? which functions? which pathways? an integrated holistic view regarding OCD and its complex genetic etiology. J Neurogenet. 2017;31(3):153-60. doi: 10.1080/01677063.2017.1336236.
Shoja Shafti S. Obsessive-compulsive traits, as behavioral invention & foundation of cultural-historical evolution: a pilot study. Am J Biomed Sci Res. 2019;3(3):201-5. doi: 10.34297/ajbsr.2019.03.000662.
Pauls DL, Abramovitch A, Rauch SL, Geller DA. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci. 2014;15(6):410-24. doi: 10.1038/nrn3746.
Hazari N, Narayanaswamy JC, Venkatasubramanian G. Neuroimaging findings in obsessive-compulsive disorder: a narrative review to elucidate neurobiological underpinnings. Indian J Psychiatry. 2019;61(Suppl 1):S9- S29. doi: 10.4103/psychiatry.IndianJPsychiatry_525_18.
Le Jeune F, Vérin M, N’Diaye K, Drapier D, Leray E, Du Montcel ST, et al. Decrease of prefrontal metabolism after subthalamic stimulation in obsessive-compulsive disorder: a positron emission tomography study. Biol Psychiatry. 2010;68(11):1016-22. doi: 10.1016/j.biopsych.2010.06.033.
Karadağ F, Kalkan Oğuzhanoğlu N, Yüksel D, Kıraç S, Cura C, Ozdel O, et al. The comparison of pre-and post-treatment (99m)Tc HMPAO brain SPECT images in patients with obsessive-compulsive disorder. Psychiatry Res. 2013;213(2):169-77. doi: 10.1016/j. pscychresns.2012.07.005.
Busatto GF, Zamignani DR, Buchpiguel CA, Garrido GE, Glabus MF, Rocha ET, et al. A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive-compulsive disorder using single photon emission computed tomography (SPECT). Psychiatry Res. 2000;99(1):15-27. doi: 10.1016/s0925-4927(00)00050-0.
Lacerda AL, Dalgalarrondo P, Caetano D, Camargo EE, Etchebehere EC, Soares JC. Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: a SPECT study. Psychiatry Res. 2003;123(2):125-34. doi: 10.1016/s0925-4927(03)00061-1.
Nikolaus S, Antke C, Beu M, Müller HW. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies. Rev Neurosci. 2010;21(2):119-39. doi: 10.1515/revneuro.2010.21.2.119.
Gürsel DA, Avram M, Sorg C, Brandl F, Koch K. Frontoparietal areas link impairments of large-scale intrinsic brain networks with aberrant fronto-striatal interactions in OCD: a meta-analysis of resting-state functional connectivity. Neurosci Biobehav Rev. 2018;87:151-60. doi: 10.1016/j.neubiorev.2018.01.016.
Hirosawa R, Narumoto J, Sakai Y, Nishida S, Ishida T, Nakamae T, et al. Reduced dorsolateral prefrontal cortical hemodynamic response in adult obsessive-compulsive disorder as measured by near-infrared spectroscopy during the verbal fluency task. Neuropsychiatr Dis Treat. 2013;9:955-62. doi: 10.2147/ndt.s45402.
Okada K, Ota T, Iida J, Kishimoto N, Kishimoto T. Lower prefrontal activity in adults with obsessive-compulsive disorder as measured by near-infrared spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:7-13. doi: 10.1016/j.pnpbp.2012.11.013.
Boedhoe PSW, Schmaal L, Abe Y, Alonso P, Ameis SH, Anticevic A, et al. Cortical abnormalities associated with pediatric and adult obsessive-compulsive disorder: findings from the ENIGMA Obsessive-Compulsive Disorder Working Group. Am J Psychiatry. 2018;175(5):453-62. doi: 10.1176/appi.ajp.2017.17050485.
Pittenger C, Bloch MH. Pharmacological treatment of obsessive-compulsive disorder. Psychiatr Clin North Am. 2014;37(3):375-91. doi: 10.1016/j.psc.2014.05.006.
Dougherty DD, Brennan BP, Stewart SE, Wilhelm S, Widge AS, Rauch SL. Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder: a review. JAMA Psychiatry. 2018;75(10):1081-7. doi: 10.1001/jamapsychiatry.2018.0930.
Jenike MA. Clinical practice. Obsessive-compulsive disorder. N Engl J Med. 2004;350(3):259-65. doi: 10.1056/ NEJMcp031002.
Dold M, Aigner M, Lanzenberger R, Kasper S. Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials. Int J Neuropsychopharmacol. 2013;16(3):557-74. doi: 10.1017/s1461145712000740.
Gholampour S, Mehrjoo S. Effect of bifurcation in the hemodynamic changes and rupture risk of small intracranial aneurysm. Neurosurg Rev. 2021;44(3):1703- 12. doi: 10.1007/s10143-020-01367-3.
Moore GJ, MacMaster FP, Stewart C, Rosenberg DR. Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1998;37(6):663-7. doi: 10.1097/00004583-199806000-00017.
Marinova Z, Chuang DM, Fineberg N. Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder. Curr Neuropharmacol. 2017;15(7):977-95. doi: 10.2174/1570159x1566617032010 4237.
Rodriguez CI, Kegeles LS, Levinson A, Feng T, Marcus SM, Vermes D, et al. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology. 2013;38(12):2475- 83. doi: 10.1038/npp.2013.150.
Simpson HB, Shungu DC, Bender J Jr, Mao X, Xu X, Slifstein M, et al. Investigation of cortical glutamate-glutamine and γ-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy. Neuropsychopharmacology. 2012;37(12):2684-92. doi: 10.1038/npp.2012.132.
Zhang Z, Fan Q, Bai Y, Wang Z, Zhang H, Xiao Z. Brain Gamma-Aminobutyric Acid (GABA) concentration of the prefrontal lobe in unmedicated patients with obsessive-compulsive disorder: a research of magnetic resonance spectroscopy. Shanghai Arch Psychiatry. 2016;28(5):263- 70. doi: 10.11919/j.issn.1002-0829.216043.
Kapur S, Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry. 1996;153(4):466-76. doi: 10.1176/ajp.153.4.466.
Monckton JE, McCormick DA. Neuromodulatory role of serotonin in the ferret thalamus. J Neurophysiol. 2002;87(4):2124-36. doi: 10.1152/jn.00650.2001.
Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev. 1995;20(1):91-127. doi: 10.1016/0165-0173(94)00007-c.
Brennan BP, Tkachenko O, Schwab ZJ, Juelich RJ, Ryan EM, Athey AJ, et al. An examination of rostral anterior cingulate cortex function and neurochemistry in obsessive-compulsive disorder. Neuropsychopharmacology. 2015;40(8):1866-76. doi: 10.1038/npp.2015.36.
Viol K, Schiepek G, Kronbichler M, Hartl A, Grafetstätter C, Strasser P, et al. Multi-level assessment of obsessive-compulsive disorder (OCD) reveals relations between neural and neurochemical levels. BMC Psychiatry. 2020;20(1):559. doi: 10.1186/s12888-020-02913-5.
Parent A, Hazrati LN. Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev. 1995;20(1):128-54. doi: 10.1016/0165-0173(94)00008- d.
Robbins TW, Gillan CM, Smith DG, de Wit S, Ersche KD. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci. 2012;16(1):81-91. doi: 10.1016/j.tics.2011.11.009.
Parmar A, Sarkar S. Neuroimaging studies in obsessive compulsive disorder: a narrative review. Indian J Psychol Med. 2016;38(5):386-94. doi: 10.4103/0253-7176.191395.
Abramovitch A, Abramowitz JS, Mittelman A. The neuropsychology of adult obsessive-compulsive disorder: a meta-analysis. Clin Psychol Rev. 2013;33(8):1163-71. doi: 10.1016/j.cpr.2013.09.004.
Gillan CM, Morein-Zamir S, Urcelay GP, Sule A, Voon V, Apergis-Schoute AM, et al. Enhanced avoidance habits in obsessive-compulsive disorder. Biol Psychiatry. 2014;75(8):631-8. doi: 10.1016/j.biopsych.2013.02.002.
Ahmari SE, Dougherty DD. Dissecting OCD circuits: from animal models to targeted treatments. Depress Anxiety. 2015;32(8):550-62. doi: 10.1002/da.22367.
Burguière E, Monteiro P, Feng G, Graybiel AM. Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science. 2013;340(6137):1243-6. doi: 10.1126/science.1232380.
Shah DB, Pesiridou A, Baltuch GH, Malone DA, O’Reardon JP. Functional neurosurgery in the treatment of severe obsessive compulsive disorder and major depression: overview of disease circuits and therapeutic targeting for the clinician. Psychiatry (Edgmont). 2008;5(9):24-33.
Lopes AC, Greenberg BD, Canteras MM, Batistuzzo MC, Hoexter MQ, Gentil AF, et al. Gamma ventral capsulotomy for obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(9):1066-76. doi: 10.1001/ jamapsychiatry.2014.1193.
Lapidus KA, Stern ER, Berlin HA, Goodman WK. Neuromodulation for obsessive-compulsive disorder. Neurotherapeutics. 2014;11(3):485-95. doi: 10.1007/ s13311-014-0287-9.
Trevizol AP, Shiozawa P, Cook IA, Sato IA, Kaku CB, Guimarães FB, et al. Transcranial magnetic stimulation for obsessive-compulsive disorder: an updated systematic review and meta-analysis. J ECT. 2016;32(4):262-6. doi: 10.1097/yct.0000000000000335.
Brennan BP, Jacoby RJ, Widge AS. A case of severe intractable contamination-based obsessive-compulsive disorder. JAMA Psychiatry. 2018;75(10):1088-9. doi: 10.1001/jamapsychiatry.2018.0927.
Mallet L, Polosan M, Jaafari N, Baup N, Welter ML, Fontaine D, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med. 2008;359(20):2121-34. doi: 10.1056/NEJMoa0708514.
Luyten L, Hendrickx S, Raymaekers S, Gabriëls L, Nuttin B. Electrical stimulation in the bed nucleus of the stria terminalis alleviates severe obsessive-compulsive disorder. Mol Psychiatry. 2016;21(9):1272-80. doi: 10.1038/ mp.2015.124.
Widge AS, Dougherty DD. Deep brain stimulation for treatment-refractory mood and obsessive-compulsive disorders. Curr Behav Neurosci Rep. 2015;2(4):187-97. doi: 10.1007/s40473-015-0049-y.
Dougherty DD, Chou T, Corse AK, Arulpragasam AR, Widge AS, Cusin C, et al. Acute deep brain stimulation changes in regional cerebral blood flow in obsessive-compulsive disorder. J Neurosurg. 2016;125(5):1087-93. doi: 10.3171/2015.9.jns151387.
Lo MC, Widge AS. Closed-loop neuromodulation systems: next-generation treatments for psychiatric illness. Int Rev Psychiatry. 2017;29(2):191-204. doi: 10.1080/09540261.2017.1282438.
Widge AS, Licon E, Zorowitz S, Corse A, Arulpragasam AR, Camprodon JA, et al. Predictors of hypomania during ventral capsule/ventral striatum deep brain stimulation. J Neuropsychiatry Clin Neurosci. 2016;28(1):38-44. doi: 10.1176/appi.neuropsych.15040089.
Widge AS, Ellard KK, Paulk AC, Basu I, Yousefi A, Zorowitz S, et al. Treating refractory mental illness with closed-loop brain stimulation: progress towards a patient-specific transdiagnostic approach. Exp Neurol. 2017;287(Pt 4):461- 72. doi: 10.1016/j.expneurol.2016.07.021.
- Abstract Viewed: 274 times
- PDF Downloaded: 428 times